Physician profile
George S Boyle
NPI 1205850286
$774.23
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $267 · 2023: $13.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $368.92 | 2019-2023 | Octrode |
| Amgen INC. | $144.70 | 2019 | |
| Biotronik INC. | $44.07 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $41.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $34.38 | 2019-2020 | |
| Boston Scientific Corporation | $22.84 | 2020 | |
| Sanofi-Aventis U.S. LLC | $21.65 | 2019 | |
| Medtronic Vascular, INC. | $21.26 | 2019 | |
| Astellas Pharma US INC | $17.85 | 2020 | |
| Cardiovascular Systems INC. | $16.74 | 2020 | |
| Amarin Pharma, INC. | $14.48 | 2019 | |
| Angiodynamics, INC. | $13.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.